In Search Of A Stimulant Use Disorder Treatment: ‘We’ve Been Doing It Wrong’

US FDA official questions whether problem is due to population selection, outcome measures, or study duration. Potential endpoints include change in disease status as measured by DSM-5 criteria, cognitive function and quality of life, experts say.

substance use disorder
Researchers seek to overcome hurdles to development of a treatment for stimulant use disorder • Source: Alamy

Despite decades of research, development of a treatment for stimulant use disorder remains elusive. Experts are now hunkering down to come with new approaches to overcome hurdles in clinical trial design and the selection of study endpoints.

“I’m quite sure we’ve been doing it wrong

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D